Cue Biopharma, Inc. revenue for the last year amounted to 5.49 M USD, the most of which — 5.49 M USD — came from its highest performing source at the moment, Injectable Biologics, the year earlier bringing 1.25 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Cue Biopharma, Inc. 5.49 M USD, and the year before that — 1.25 M USD.